Comparison of RNA extraction kits and histological stains for laser capture microdissected prostate tissue by Kolijn, K. (Kimberley) & Leenders, G.J.H.L. (Geert)
Kolijn and van Leenders  BMC Res Notes  (2016) 9:17 
DOI 10.1186/s13104-015-1813-5
TECHNICAL NOTE
Comparison of RNA extraction kits 
and histological stains for laser capture 
microdissected prostate tissue
Kimberley olijn* and Geert J. L. H. van Leendeers
Abstract 
Background: Laser capture microdissection offers unique possibilities for the isolation of specific cell populations or 
histological structures. However, isolation of RNA from microdissected tissue is challenging due to degradation and 
minimal yield of RNA during laser capture microdissection (LCM). Our aim was to optimize the isolation of high-qual-
ity RNA from laser capture microdissected fresh frozen prostate tissue on the level of staining and RNA extraction.
Results: Cresyl violet and haematoxylin were compared as histological stains for LCM. While RNA quality was 
similar for cresyl violet (median RIN 7.4) and haematoxylin (median RIN 7.6), tissue morphology was more detailed 
with cresyl violet as compared to haematoxylin. RNA quality from the following kits was compared: RNeasy® Micro 
(median RIN 7.2), miRNeasy Mini (median RIN 6.6), Picopure® (median RIN 6.0), mirVana™ miRNA (median RIN 6.5) 
and RNAqueous®-Micro (median RIN 6.3). RNA quality from microdissected samples with either the RNeasy Micro or 
miRNeasy Mini kit, was comparable to RNA isolated directly from whole tissue slices (median RIN 7.5, p = 0.09). Iso-
lated RNA from benign and prostate cancer microdissected tissue demonstrated that RNA quality can vary between 
regions from the same clinical sample. Additionally, RNA quality (r = 0.89), but not quantity (r = 0.69) could be pre-
cisely measured with the Agilent Bioanalyzer.
Conclusions: We demonstrate that staining with cresyl violet results in the isolation of high quality RNA from laser 
capture microdissected tissue with high discriminative morphology. The RNeasy Micro and miRNeasy Mini RNA 
extraction kits generated the highest quality RNA compared to Picopure, mirVana and RNAqueous with minimal loss 
of RNA quality during LCM.
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Findings
Biological and histological heterogeneity of tissue sam-
ples are challenging issues for the isolation and charac-
terization of individual cell populations that typically 
comprise tissues such as epithelial, mesenchymal and 
immune cells. Techniques such as macrodissection pro-
duce samples consisting of a mixture of cell types. Laser 
capture microdissection (LCM) is a method to obtain 
samples containing one specific cell type from com-
plex tissues based on phenotypical, cytological and his-
topathological features. Generally, stained tissue slices 
are observed in an inverted light microscope and under 
visual guidance, areas of interest are cut loose using a 
focused laser beam. Excised fragments are catapulted 
into a specialized tube and protein, RNA or DNA are 
subsequently extracted for molecular profiling tech-
niques such as gene-expression analysis or proteomics. 
The extraction of RNA from fresh frozen prostate tissue 
is particularly challenging due to its rapid degradation by 
RNases and low quantities of material usually obtained 
through LCM.
In this study, we describe a protocol for the isolation 
of high quality RNA from fresh frozen prostate tissue 
including tissue handling, staining and RNA extraction 
kits of procured RNA (Fig. 1, Additional file 1).
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To obtain high quality RNA from any type of tissue, 
optimization of steps that precede the LCM process are 
essential. In order to perform LCM on tissue slides, a his-
tological stain is needed to discern the various cell types 
and structures present in the tissue. A widely used stain is 
haematoxylin, a staining method based on the reaction of 
haematein with DNA [1]. Metal ions in the DNA are used 
a mordant, giving a blue color to the nuclei. Cresyl violet 
or NissI staining uses a basic aniline dye that stains RNA, 
and thus the endoplasmic reticulum and ribosomes blue 
[2]. Others have compared these histological stains for 
other tissue types and cell lines, but not microdissected 
prostate cancer (PCa) tissue [3, 4]. We have compared the 
RNA quality of microdissected PCa tissue stained with 
haematoxylin or cresyl violet (Fig. 2a). Consecutive PCa 
tissue sections were stained with haematoxylin (n  =  5) 
and cresyl violet (n  =  5) and matching tumor regions 
from the same patient were isolated through LCM. As a 
control, RNA was isolated from one complete tissue slice 
immediately after cutting. The quality of RNA was subse-
quently measured with the Agilent Bioanalyzer as RNA 
integrity number (RIN).
The quality of RNA was similar for cresyl violet 
(median RIN 7.4) and haematoxylin (median RIN 7.6, 
p  =  0.71) stained sections. However, the morphology 
of the tissue was much better visualized in cresyl violet 
treated slides (Fig.  2b). Studies have demonstrated that 
cresyl violet staining is also preferred for RNA isolation 
in breast and endometrium [5, 6]. Therefore, we applied 
cresyl violet staining for all further optimization steps.
RNA quality is dependent on RNA extraction kit
There are several commercial RNA extraction kits avail-
able that allow the isolation of RNA from tissue such as 
RNeasy® Micro (RNeasy), miRNeasy Mini (miRNeasy), 
Arcturus® Picopure® RNA isolation kit (Picopure), mir-
Vana™ miRNA isolation kit (mirVana) and RNAqueous®-
Micro (RNAqueous). Several studies have compared 
different RNA extraction kits on samples other than 
microdissected tissue [7–9]. Additionally, the prepara-
tion and process of LCM has been optimized for various 
tissues, including prostate [3, 10, 11]. However, to our 
knowledge there have been no reports on which RNA 
extraction kit is most suited for the isolation of RNA 
from microdissected (prostate) tissue. Therefore, we 
sought out to determine which RNA extraction kits can 
provide the best quality from fresh frozen prostate tissue 
fragments isolated through LCM.
RNA was extracted in parallel from microdissected 
PCa and benign regions from three patients in duplicate 
using each of the 5 RNA isolation kits (total of 60 LCM 
samples). Matching tissue regions (PCa and benign) were 
microdissected from the prostate tissue with a similar 
surface area (7  mm2). Additionally, RNA was isolated 
from a whole tissue slice (10 µm) from the same patient 
in duplicate with each kit, as a control for potential LCM 
quality loss (n  =  30). PCa cell lines PC3, LNCaP and 
DU145 served as a control for high quality RNA control 
during each isolation round (n = 20) [12]. The duration 
of the LCM was kept within a maximum of 1 h to mini-
mize RNA degradation, although RNA quality remained 
stable for at least 2 h (data not shown).
First, we compared RIN values of RNA isolated with 
the RNeasy (median RIN 7.2), miRNeasy (median RIN 
6.6), Picopure (median RIN 6.0), Mirvana (median RIN 
6.5) and RNAqueous (median RIN 6.3) extraction kits, 
respectively (Fig.  3a). The main difference between the 
RNeasy and miRNeasy kits is the option in the latter to 
enrich for micro RNAs in the sample. The RNeasy and 
miRNeasy kits gave the best quality RNA and led to suc-
cessful RNA isolation of every sample. Both the mir-
Vana (2 out of 12 samples) and RNAqueous (3 out of 
12 samples) kits failed more often to isolate RNA from 
microdissected tissue. RIN values of the RNeasy sam-
ples were significantly higher than those obtained with 
the Picopure (p = 0.01) samples, but the differences were 
not found to be significant with RNAqueous (p = 0.08), 
miRNeasy (p  =  0.57) or mirVana (p  =  0.34). However, 
the number of samples was too low to conclude that the 
RNeasy and miRNEasy kit are truly superior to the other 
tested RNA extraction kits. Additionally, we found that 
the quality of extracted RNA can vary between benign 
Fig. 1 Procedural overview for the isolation of RNA from fresh frozen microdissected prostate tissue. Primary prostate tissue was sectioned and the 
sections were transferred to a membrane slide. After staining, areas of interest were microscopically identified and excised by microdissection. RNA 
was extracted from the tissue fragments using one of several commercial kits. Quality and quantity of RNA were measured with the Agilent Bioana-
lyzer. In a selection of RNA samples, the amount of two transcripts characteristic of prostate cancer were measured by quantitative PCR
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and PCa areas of the same slide (Fig.  3b). In the first 
patient, RNA extracted from benign tissue showed simi-
lar quality (median RIN 6.7) as that extracted from PCa 
tissue (median RIN 6.4, p =  0.84). However, in the sec-
ond (RIN 6.0 vs 6.8) and third patient (RIN 7.5 vs 6.2), 
RNA isolated from benign tissue and PCa cells was sig-
nificantly different (p = 0.04 and p = 0.02 respectively). 
This difference may be due to local changes in ribonu-
clease activity. Studies on the expression of RNases in 
tumors are contradictory, although it has been suggested 
that RNase activity decreases in rapidly growing tumors 
[13]. The amount of blood loss during prostatectomy and 
tumor stroma content have also been shown to affect 
RNA degradation [14]. However, RNA quality can also 
vary in general throughout tissue slices, independent of 
morphology.
The overall quality of RNA obtained with the RNeasy 
or miRNeasy kit from control cell lines (n = 9), whole tis-
sue sections (n = 12) and benign and PCa LCM material 
(n = 24) was compared (Fig. 4). As expected, the average 
quality of RNA obtained from PCa cell lines was signifi-
cantly higher (median RIN 8.3) than from LCM material 
(median RIN 7.0, p < 0.001). However, the LCM samples 
still generated high quality RNA that was comparable to 
RNA from whole tissue sections from the same patients 
(median RIN 7.5, p =  0.09). Therefore, we demonstrate 
that high quality RNA can be isolated from microdis-
sected tissue with only a small quality loss (±0.5 RIN) 
compared to whole tissue slices. Additionally, we found 
that the RNA quality of whole tissue sections was a good 
indication on the RNA quality of microdissected material 
taken from the same tissue sections. We would therefore 
recommend to test overall tissue quality prior to LCM. 
To confirm that the extracted RNA was reflective of the 
morphological origin (benign versus PCa), we performed 
amplification and quantitative PCR on RNA from nor-
mal (n  =  3) and PCa (n  =  3) LCM (RNeasy) samples 
with primers directed against the metabolic enzyme 
alpha-methylacyl-coenzyme A racemace (AMACR) and 
the serine protease hepsin. These proteins are frequently 
overexpressed in PCa [15–17]. AMACR and hepsin were 
upregulated 40- and 13- fold respectively in all three 
tested PCa samples compared to the respective benign 
tissue (results not shown). Overall, these results demon-
strates that RNA isolated from LCM samples with our 
workflow provides high quality RNA, which could be 
used for further downstream analyses. A complete step 
by step protocol for the isolation of high quality RNA 
Fig. 2 RNA quality of microdissected prostate cancer tissue stained with cresyl violet or haematoxylin. Consecutive slides from the same patient 
were stained with either cresyl violet (CV) or haematoxylin (HT), and matching tumor regions were isolated through LCM using whole tissue as 
control. While RIN values of microdissected tissues stained for cresyl violet or haematoxylin were similar (a), the morphology of cresyl violet stained 
slides was significantly more detailed than haematoxylin stained slides (b). Symbols represent material from the same patient. Median RIN values 
are shown, whiskers indicate interquartile range
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from prostate tissue is included as a supplementary file 
(Additional file 1).
RNA quality, not quantity, can be precisely measured 
with the Agilent Bioanalyzer
The Bioanalyzer is a very sensitive instrument that can 
measure picograms of RNA material. However, this also 
implies that contaminants can have a major impact on the 
final measurements. For example, we often encountered 
‘ghost peaks’ in the electropherograms generated by the 
Bioanalyzer that would impede the interpretation of the 
electropherogram. Therefore, we tested the reproducibil-
ity of RNA quality and quantity measurements with the 
Bioanalyzer by comparing the results obtained in dupli-
cate analyses of the same samples (Fig.  5). RIN values 
measured in the same sample with different microfluidic 
chips were strongly correlated (Fig.  5a, r =  0.89). How-
ever, the correlation between RNA quantities was low 
(Fig. 5b, r = 0.68). As the quantities of RNA samples are 
based on the ladder of each individual microfluidic chip, 
variations between ladder batches may attribute to the 
low correlation between quantity measurements. In con-
clusion, RIN values are consistently measured with a Bio-
analyzer, but not RNA quantity.
The isolation of high-quality RNA from LCM material 
is a major challenge. In this study, we provide a working 
protocol for the isolation of high quality RNA from fresh 
frozen prostate tissue (Additional file  1). We found that 
the use of cresyl violet as a histological stains permits 
the isolation of high quality RNA from LCM prostate tis-
sue with good discriminative tissue morphology. We also 
demonstrated that the applied RNA extraction kit can 
influence the quality of isolated RNA and that the RNeasy 
and miRNeasy kits consistently deliver high quality sam-
ples reflective of morphological origin. Furthermore, the 
RNA quality can vary within the same tissue slice. Finally, 
we showed that the Agilent Bioanalyzer can reproducibly 
determine RNA quality, but not quantity. This should be 
taken into consideration when samples are subsequently 
used for experiments that require precise input quantities.
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Fig. 3 Comparison of RNA extraction kits for microdissected samples. 
RNA quality for benign and PCa LCM samples are shown for all RNA 
extraction kits. RIN values are shown as the average of a duplicate 
experiment. RNeasy and miRNeasy consistently delivered high qual-
ity RNA from LCM samples (a). Median RIN values were compared 
between the groups, which were expected to be similar. However, 
RNeasy generated higher quality RNA than Picopure and RNAqueous 
(p = 0.01 and 0.08 respectively). Additionally, RNA quality between 
benign glands and PCa cells within the same patient was variable (b)
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Fig. 4 RNA integrity values for material isolated from LCM samples, 
whole tissue slices and cell lines. RNA quality (RIN values) for LCM 
derived samples, whole tissue slices and cell lines isolated with the 
RNeasy or miRNeasy kits. Median RIN values are shown, whiskers 
indicate interquartile range
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Methods
Clinical specimens and prostate cancer cell lines
Radical prostatectomy (RP) specimens were derived 
from the archive of the department of pathology, Eras-
mus Medical Centre, Rotterdam, The Netherlands. All 
RP’s had been performed in our institute between July 
2010 and May 2013, prompted by histologically proven 
hormone-naïve PCa on diagnostic needle-biopsy. After 
receipt of RP specimens at the department of pathology, 
a transverse tissue slice was frozen in liquid nitrogen for 
research purposes and evaluated by a urogenital patholo-
gist (GvL). Patients in Erasmus MC consent with the use 
of remaining tissue for research purposes based on an 
opt-out procedure, which was approved by the local Med-
ical Ethical Committee (MEC 2011-195 and 2011-196). 
The opt-out procedure is a national well-accepted regula-
tory method during which the patient is informed verbally 
and can object against the use of the remaining tissue in 
written form. This procedure was developed by the FED-
ERA (Federation of Dutch Medical Scientific societies) 
and described in an official code of conduct (Human Tis-
sue and Medical Research: Code of conduct for responsi-
ble use, 2011). Prostate cancer cells lines PC3, LNCaP and 
DU145 were used as a control for isolation of high quality 
RNA. Cell lines were obtained from the American Type 
Culture Collection (ATCC, Rockville, MD, USA) and 
maintained at 37  °C/5  % CO2 in RPMI 1640 containing 
5 % fetal calf serum (Beohringer, Germany) and penicillin/
streptomycin (P/S) (Lonza, Belgium).
Fresh frozen tissue handling and laser capture 
microdissection
Fresh frozen prostate tissue was stored in liquid nitrogen 
or at -80  °C. Polyethylene naphthalate (PEN) membrane 
slides (MembraneSlide 1.0 PEN, Carl Zeiss, Germany) 
were pretreated under a UV light (UV Curing Lamp, 
Instrumedics Inc., USA.) for 30  min. Tissues from three 
patients were cut in 10  µm slices in a cryostat (Microm 
HM 560, Adamas Instrumenten, the Netherlands) at 
−26 °C with Tissue-Tek O.C.T. Compound (Sakura Fine-
tek Europe, the Netherlands) and mounted on PEN slides. 
Slides were immediately transferred to dry ice in slide 
boxes (Sliderite 5 mailer, CellPath, U.K.), wrapped in tin 
foil and stored at −80 °C. One whole tissue slice was cut, 
transferred to a Eppendorf tube and stored −80 °C as con-
trol. For staining and dehydration of tissue, frozen slices 
were transferred directly to the following pre-cooled 
solutions on ice: 70  % ethanol for 1  min, distilled water 
(Gibco, Life Technologies, USA.) for 30 s, 1 % cresyl vio-
let in 50 % ethanol (Cresyl Violet acetate, Sigma–Aldrich, 
the Netherlands) or haematoxylin (Klinipath, the Nether-
lands) for 2 min, 70 % ethanol for 1 min and 100 % ethanol 
for 1 min. Slides were immediately processed with LCM 
using a Zeiss PALM® Microbeam IV (Carl Zeiss, Ger-
many) at room temperature for a maximum of 1 h. Laser 
focus and energy settings were optimized for every slide 
to minimize damage from laser cutting of the tissue. Tis-
sue was captured in AdhesiveCap500 opaque tubes (Carl 
Zeiss, Germany), put on dry ice and stored at −80 °C.
a
2
4
6
8
10
2 4 6 8 10
RIN value Picochip 2
r=0.89
RI
N
 v
al
ue
 P
ic
oc
hi
p 
1
b
0
RNA quantity chip 2 (ng)
r=0.68
RN
A
 q
ua
nt
ity
 c
hi
p 
1 
(n
g)
0 50 100 150
50
100
150
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ured RNA quality values was high (r = 0.89). Measurement of RNA quantity level varied between duplicate readings (r = 0.68)
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RNA extraction and measurement
The following RNA extraction kits were used to iso-
late total RNA from LCM acquired material: RNeasy® 
Micro (Qiagen, Germany), miRNeasy Mini (Qiagen, Ger-
many), Arcturus® Picopure® RNA isolation kit (Arcturus, 
Applied Biosystems, USA.), mirVana™ miRNA isolation 
kit (Ambion, USA.) and RNAqueous®-Micro (Ambion, 
USA.). Samples were taken from a −80  °C freezer and 
lysis buffer from the according RNA extraction kit was 
immediately added to the sample at room temperature. 
Buffer and tissue were mixed for 30  s through pipet-
ting and left on the bench for 5  min to assure proper 
lysis. Extraction was performed according to manufac-
turer’s protocols with an on-column DNAse digestion 
step (RNase-Free DNase set, Qiagen, Germany) added 
after the first wash buffer step for each kit. RNA qual-
ity and quantity was measured in duplicate with a 2100 
Bioanalyzer and the RNA 6000 Pico Kit according to 
manufacturer’s protocol (Agilent Technologies, USA.). 
An additional water wash step of the Bionalyzer elec-
trodes was added prior to PicoChip analysis to minimize 
RNaseZap (Applied Biosystems, USA.) associated ghost 
peaks.
Statistics
Median RIN values from cresyl violet and haematoxylin 
LCM samples were compared with a Wilcoxon matched-
pairs signed rank test. The non-parametric Mann–Whit-
ney U test was used to compare median RIN values for 
RNA quality from LCM, cell lines and tissue samples 
from the observed differences between groups. Correla-
tion of RIN values and RNA quantity between chips was 
calculated with Pearson’s r test. All graphs and statistics 
were performed in GraphPad Prism (version 3.0). p val-
ues <0.05 were considered significant.
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